Lisinopril Tablets USP — Class II drug recall D-1077-2018
Terminated recall by Lupin Pharmaceuticals Inc., reported 2018-08-22, distributed nationwide. Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
| Recall number | D-1077-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2018-08-13 |
| Classified | 2018-08-13 |
| Reported by FDA | 2018-08-22 |
| Terminated | 2019-10-15 |
| Distributed | Nationwide (US) |
| Quantity | 11,706 bottles |
| NDC | 68180-0512, 68180-0512-01, 68180-0512-02, 68180-0512-03, 68180-0512-09, 68180-0512-30, 68180-0513, 68180-0513-01, 68180-0513-02, 68180-0513-03, 68180-0513-05, 68180-0513-09, 68180-0513-30, 68180-0514, 68180-0514-01, 68180-0514-02, 68180-0514-03, 68180-0514-05, 68180-0514-09, 68180-0514-30, 68180-0515, 68180-0515-01, 68180-0515-02, 68180-0515-03, 68180-0515-05 and 40 more |
| Lot numbers | H800414 |
| Expiration dates | 2019-12 |
Product
Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03
Reason for recall
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1077-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.